Javascript doit fonctionner ! Activez-le et rechargez cette page.
Le Rézo de JeuxDeMots
• Types de relations
• Types de noeuds
• Consolider
le terme
  Options  
             

  Filtrage type relations : +   - (ex: 4, 12, 18, 36, 444, 555, 777)
  Filtrage valeur :          min   max
  Filtrage type noeuds :   +   - (ex: 4, 6, 8, 9, 10, 12, 18, 36, 444, 555, 777)

  Présentation de sortie :   (ex: -rien-, cloud, nicecloud)
 

'en:4scar-gd2-modified t-lymphocytes'
(id=6891620 ; fe=en:4scar-gd2-modified t-lymphocytes ; type=1 ; niveau=200 ; luminosité=25 ; somme entrante=8532.619995117188 creation date=2017-06-25 touchdate=2025-08-31 22:49:28.000)
≈ 163 relations sortantes

  1. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 42 / 1 -> en:antiserum
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:antiserum | rel=r_associated | relid=0 | w=42
  2. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 42 / 1 -> en:bone meal
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:bone meal | rel=r_associated | relid=0 | w=42
  3. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 42 / 1 -> en:denileukin diftitox
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:denileukin diftitox | rel=r_associated | relid=0 | w=42
  4. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 42 / 1 -> en:gene therapy agent
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:gene therapy agent | rel=r_associated | relid=0 | w=42
  5. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 42 / 1 -> en:human immunoglobulin a
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:human immunoglobulin a | rel=r_associated | relid=0 | w=42
  6. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 42 / 1 -> en:interleukin-11
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:interleukin-11 | rel=r_associated | relid=0 | w=42
  7. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 42 / 1 -> en:transduction gene
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:transduction gene | rel=r_associated | relid=0 | w=42
  8. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 41 / 0.976 -> en:blood derivative product
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:blood derivative product | rel=r_associated | relid=0 | w=41
  9. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 41 / 0.976 -> en:blood material
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:blood material | rel=r_associated | relid=0 | w=41
  10. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 41 / 0.976 -> en:c46/ccr5/p140k lentiviral vector-transduced autologous hspcs
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:c46/ccr5/p140k lentiviral vector-transduced autologous hspcs | rel=r_associated | relid=0 | w=41
  11. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 41 / 0.976 -> en:ovine digoxin immune fab
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:ovine digoxin immune fab | rel=r_associated | relid=0 | w=41
  12. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 40 / 0.952 -> en:cells [chemical/ingredient]
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:cells [chemical/ingredient] | rel=r_associated | relid=0 | w=40
  13. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 40 / 0.952 -> en:dehydrated human amnion/chorion membrane
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:dehydrated human amnion/chorion membrane | rel=r_associated | relid=0 | w=40
  14. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 40 / 0.952 -> en:umbilical cord blood-derived hematopoietic cd34-positive progenitor cells
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:umbilical cord blood-derived hematopoietic cd34-positive progenitor cells | rel=r_associated | relid=0 | w=40
  15. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 39 / 0.929 -> en:immunologic factors
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:immunologic factors | rel=r_associated | relid=0 | w=39
  16. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 39 / 0.929 -> en:vaccine, immunoglobulins and antisera
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:vaccine, immunoglobulins and antisera | rel=r_associated | relid=0 | w=39
  17. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 38 / 0.905 -> en:anti-cd22 car-expressing t lymphocytes
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:anti-cd22 car-expressing t lymphocytes | rel=r_associated | relid=0 | w=38
  18. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 38 / 0.905 -> en:escherichia coli antibody
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:escherichia coli antibody | rel=r_associated | relid=0 | w=38
  19. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 38 / 0.905 -> en:hsp70-peptide tkd/il-2-activated autologous natural killer cells
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:hsp70-peptide tkd/il-2-activated autologous natural killer cells | rel=r_associated | relid=0 | w=38
  20. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 38 / 0.905 -> en:lenti-d/abcd1-transduced autologous hematopoietic stem cells
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:lenti-d/abcd1-transduced autologous hematopoietic stem cells | rel=r_associated | relid=0 | w=38
  21. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 37 / 0.881 -> en:recombinant human serum amyloid p/pentraxin 2
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:recombinant human serum amyloid p/pentraxin 2 | rel=r_associated | relid=0 | w=37
  22. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 36 / 0.857 -> en:antisense oligonucleotides
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:antisense oligonucleotides | rel=r_associated | relid=0 | w=36
  23. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 36 / 0.857 -> en:autologous anti-hpv-16 e6 t-cell receptor gene-engineered peripheral blood lymphocytes
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:autologous anti-hpv-16 e6 t-cell receptor gene-engineered peripheral blood lymphocytes | rel=r_associated | relid=0 | w=36
  24. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 36 / 0.857 -> en:autologous mesenchymal stem cells apceth_101
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:autologous mesenchymal stem cells apceth_101 | rel=r_associated | relid=0 | w=36
  25. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 36 / 0.857 -> en:blood product
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:blood product | rel=r_associated | relid=0 | w=36
  26. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 36 / 0.857 -> en:luspatercept
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:luspatercept | rel=r_associated | relid=0 | w=36
  27. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 36 / 0.857 -> en:monoclonal antibody
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:monoclonal antibody | rel=r_associated | relid=0 | w=36
  28. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 36 / 0.857 -> en:neurotransmitter
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:neurotransmitter | rel=r_associated | relid=0 | w=36
  29. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 36 / 0.857 -> en:receptor
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:receptor | rel=r_associated | relid=0 | w=36
  30. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 36 / 0.857 -> en:synthetic copolymer
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:synthetic copolymer | rel=r_associated | relid=0 | w=36
  31. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 36 / 0.857 -> en:thrombopoietin receptor agonist lgd-4665
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:thrombopoietin receptor agonist lgd-4665 | rel=r_associated | relid=0 | w=36
  32. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 36 / 0.857 -> en:toxoids
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:toxoids | rel=r_associated | relid=0 | w=36
  33. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 36 / 0.857 -> en:vaccine, immunoglobulin, and/or antiserum
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:vaccine, immunoglobulin, and/or antiserum | rel=r_associated | relid=0 | w=36
  34. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 36 / 0.857 -> en:viruses ingredient
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:viruses ingredient | rel=r_associated | relid=0 | w=36
  35. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 35 / 0.833 -> en:autologous cd34-positive hematopoietic progenitor cells
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:autologous cd34-positive hematopoietic progenitor cells | rel=r_associated | relid=0 | w=35
  36. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 35 / 0.833 -> en:beractant
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:beractant | rel=r_associated | relid=0 | w=35
  37. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 35 / 0.833 -> en:blood group antigen carrier
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:blood group antigen carrier | rel=r_associated | relid=0 | w=35
  38. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 35 / 0.833 -> en:blood group antigen precursor
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:blood group antigen precursor | rel=r_associated | relid=0 | w=35
  39. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 35 / 0.833 -> en:bovine pituitary extract
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:bovine pituitary extract | rel=r_associated | relid=0 | w=35
  40. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 35 / 0.833 -> en:calfactant
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:calfactant | rel=r_associated | relid=0 | w=35
  41. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 35 / 0.833 -> en:cord blood-derived expanded natural killer cells pnk-007
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:cord blood-derived expanded natural killer cells pnk-007 | rel=r_associated | relid=0 | w=35
  42. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 35 / 0.833 -> en:dendritic cell-precision multiple antigen t-lymphocytes
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:dendritic cell-precision multiple antigen t-lymphocytes | rel=r_associated | relid=0 | w=35
  43. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 35 / 0.833 -> en:enzyme replacement or supplement agent
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:enzyme replacement or supplement agent | rel=r_associated | relid=0 | w=35
  44. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 35 / 0.833 -> en:gene transfer or gene delivery agent
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:gene transfer or gene delivery agent | rel=r_associated | relid=0 | w=35
  45. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 35 / 0.833 -> en:gene-modified hiv-protected hematopoietic stem cells
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:gene-modified hiv-protected hematopoietic stem cells | rel=r_associated | relid=0 | w=35
  46. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 35 / 0.833 -> en:genetically engineered hematopoietic stem progenitor cells
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:genetically engineered hematopoietic stem progenitor cells | rel=r_associated | relid=0 | w=35
  47. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 35 / 0.833 -> en:interleukin-2
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:interleukin-2 | rel=r_associated | relid=0 | w=35
  48. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 35 / 0.833 -> en:nervous system hormone-like substance
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:nervous system hormone-like substance | rel=r_associated | relid=0 | w=35
  49. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 35 / 0.833 -> en:saccharomyces cerevisiae rna
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:saccharomyces cerevisiae rna | rel=r_associated | relid=0 | w=35
  50. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 34 / 0.81 -> en:lymphoma taa-specific cytotoxic t lymphocytes
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:lymphoma taa-specific cytotoxic t lymphocytes | rel=r_associated | relid=0 | w=34
  51. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 32 / 0.762 -> en:acellular cadaveric dermal matrix
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:acellular cadaveric dermal matrix | rel=r_associated | relid=0 | w=32
  52. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 32 / 0.762 -> en:autologous chondrocyte cell preparation
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:autologous chondrocyte cell preparation | rel=r_associated | relid=0 | w=32
  53. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 32 / 0.762 -> en:biosimilar pharmaceuticals
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:biosimilar pharmaceuticals | rel=r_associated | relid=0 | w=32
  54. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 32 / 0.762 -> en:dual variable domain immunoglobulin abt-165
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:dual variable domain immunoglobulin abt-165 | rel=r_associated | relid=0 | w=32
  55. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 32 / 0.762 -> en:expanded umbilical cord blood product hsc835
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:expanded umbilical cord blood product hsc835 | rel=r_associated | relid=0 | w=32
  56. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 32 / 0.762 -> en:gene
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:gene | rel=r_associated | relid=0 | w=32
  57. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 32 / 0.762 -> en:growth substances
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:growth substances | rel=r_associated | relid=0 | w=32
  58. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 32 / 0.762 -> en:human immunoglobulin m
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:human immunoglobulin m | rel=r_associated | relid=0 | w=32
  59. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 32 / 0.762 -> en:lentivirus vector rhiv7-shi-tar-ccr5rz-transduced hematopoietic progenitor cells
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:lentivirus vector rhiv7-shi-tar-ccr5rz-transduced hematopoietic progenitor cells | rel=r_associated | relid=0 | w=32
  60. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 32 / 0.762 -> en:superagonist interleukin-15:interleukin-15 receptor alphasu/fc fusion complex alt-803
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:superagonist interleukin-15:interleukin-15 receptor alphasu/fc fusion complex alt-803 | rel=r_associated | relid=0 | w=32
  61. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 32 / 0.762 -> en:therapeutic angiotensin-(1-7)
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:therapeutic angiotensin-(1-7) | rel=r_associated | relid=0 | w=32
  62. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 31 / 0.738 -> en:alpha-1-proteinase inhibitor human
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:alpha-1-proteinase inhibitor human | rel=r_associated | relid=0 | w=31
  63. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 31 / 0.738 -> en:anti-prolactin receptor antibody lfa102
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:anti-prolactin receptor antibody lfa102 | rel=r_associated | relid=0 | w=31
  64. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 31 / 0.738 -> en:botulinum toxins
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:botulinum toxins | rel=r_associated | relid=0 | w=31
  65. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 31 / 0.738 -> en:cathelicidin ll-37
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:cathelicidin ll-37 | rel=r_associated | relid=0 | w=31
  66. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 31 / 0.738 -> en:chemotactic factor inactivator
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:chemotactic factor inactivator | rel=r_associated | relid=0 | w=31
  67. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 31 / 0.738 -> en:colony stimulating factor
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:colony stimulating factor | rel=r_associated | relid=0 | w=31
  68. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 31 / 0.738 -> en:donor regulatory t-lymphocytes
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:donor regulatory t-lymphocytes | rel=r_associated | relid=0 | w=31
  69. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 31 / 0.738 -> en:gelatin
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:gelatin | rel=r_associated | relid=0 | w=31
  70. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 31 / 0.738 -> en:genetically engineered ny-eso-1-specific t lymphocytes
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:genetically engineered ny-eso-1-specific t lymphocytes | rel=r_associated | relid=0 | w=31
  71. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 31 / 0.738 -> en:her2-targeting antibody fc fragment fs102
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:her2-targeting antibody fc fragment fs102 | rel=r_associated | relid=0 | w=31
  72. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 31 / 0.738 -> en:igf-1r antisense oligodeoxynucleotide-treated autologous glioma cells
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:igf-1r antisense oligodeoxynucleotide-treated autologous glioma cells | rel=r_associated | relid=0 | w=31
  73. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 31 / 0.738 -> en:ny-eso-1-specific cd4-positive t lymphocytes
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:ny-eso-1-specific cd4-positive t lymphocytes | rel=r_associated | relid=0 | w=31
  74. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 31 / 0.738 -> en:red yeast rice
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:red yeast rice | rel=r_associated | relid=0 | w=31
  75. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 31 / 0.738 -> en:therapeutic autologous lymphocytes
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:therapeutic autologous lymphocytes | rel=r_associated | relid=0 | w=31
  76. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 31 / 0.738 -> en:vaccine
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:vaccine | rel=r_associated | relid=0 | w=31
  77. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 30 / 0.714 -> en:autologous pbmcs in gm-csf
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:autologous pbmcs in gm-csf | rel=r_associated | relid=0 | w=30
  78. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 30 / 0.714 -> en:biological warfare agents
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:biological warfare agents | rel=r_associated | relid=0 | w=30
  79. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 30 / 0.714 -> en:cd138car-cd137/tcrzeta-expressing t lymphocytes
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:cd138car-cd137/tcrzeta-expressing t lymphocytes | rel=r_associated | relid=0 | w=30
  80. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 30 / 0.714 -> en:gene transduction agent
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:gene transduction agent | rel=r_associated | relid=0 | w=30
  81. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 30 / 0.714 -> en:interferon beta-secreting mesenchymal stem cells
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:interferon beta-secreting mesenchymal stem cells | rel=r_associated | relid=0 | w=30
  82. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 30 / 0.714 -> en:nutrient
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:nutrient | rel=r_associated | relid=0 | w=30
  83. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 30 / 0.714 -> en:picibanil
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:picibanil | rel=r_associated | relid=0 | w=30
  84. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 30 / 0.714 -> en:plant preparations
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:plant preparations | rel=r_associated | relid=0 | w=30
  85. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 30 / 0.714 -> en:protein-bound iodine
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:protein-bound iodine | rel=r_associated | relid=0 | w=30
  86. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 30 / 0.714 -> en:recombinant human apolipoprotein(a) kringle v mg1102
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:recombinant human apolipoprotein(a) kringle v mg1102 | rel=r_associated | relid=0 | w=30
  87. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 30 / 0.714 -> en:serum-derived bovine immunoglobulin protein isolate
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:serum-derived bovine immunoglobulin protein isolate | rel=r_associated | relid=0 | w=30
  88. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 30 / 0.714 -> en:therapeutic allogeneic lymphocytes
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:therapeutic allogeneic lymphocytes | rel=r_associated | relid=0 | w=30
  89. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 30 / 0.714 -> en:tumor-cells apoptosis factor hormone-peptide
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:tumor-cells apoptosis factor hormone-peptide | rel=r_associated | relid=0 | w=30
  90. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 30 / 0.714 -> en:ularitide
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:ularitide | rel=r_associated | relid=0 | w=30
  91. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 29 / 0.69 -> en:anti-tumor necrosis factor alpha drug
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:anti-tumor necrosis factor alpha drug | rel=r_associated | relid=0 | w=29
  92. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 29 / 0.69 -> en:bcma-specific car-expressing t lymphocytes
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:bcma-specific car-expressing t lymphocytes | rel=r_associated | relid=0 | w=29
  93. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 29 / 0.69 -> en:biological control agents
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:biological control agents | rel=r_associated | relid=0 | w=29
  94. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 29 / 0.69 -> en:fap-specific cd8-positive t cells
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:fap-specific cd8-positive t cells | rel=r_associated | relid=0 | w=29
  95. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 29 / 0.69 -> en:hematopoietic factor
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:hematopoietic factor | rel=r_associated | relid=0 | w=29
  96. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 29 / 0.69 -> en:heterodimeric interleukin-15
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:heterodimeric interleukin-15 | rel=r_associated | relid=0 | w=29
  97. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 29 / 0.69 -> en:human immunoglobulin g
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:human immunoglobulin g | rel=r_associated | relid=0 | w=29
  98. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 29 / 0.69 -> en:human menopausal gonadotropin
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:human menopausal gonadotropin | rel=r_associated | relid=0 | w=29
  99. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 29 / 0.69 -> en:inducible cd4+cd25+ regulatory t cells
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:inducible cd4+cd25+ regulatory t cells | rel=r_associated | relid=0 | w=29
  100. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 29 / 0.69 -> en:live yeast cell derivative
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:live yeast cell derivative | rel=r_associated | relid=0 | w=29
  101. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 29 / 0.69 -> en:mesothelin-specific chimeric antigen receptor-engineered peripheral blood lymphocytes
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:mesothelin-specific chimeric antigen receptor-engineered peripheral blood lymphocytes | rel=r_associated | relid=0 | w=29
  102. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 29 / 0.69 -> en:organic natural material
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:organic natural material | rel=r_associated | relid=0 | w=29
  103. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 29 / 0.69 -> en:plant nectar
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:plant nectar | rel=r_associated | relid=0 | w=29
  104. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 29 / 0.69 -> en:sirna-transfected peripheral blood mononuclear cells apn401
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:sirna-transfected peripheral blood mononuclear cells apn401 | rel=r_associated | relid=0 | w=29
  105. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 28 / 0.667 -> en:adipose-derived stromal vascular fraction cells
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:adipose-derived stromal vascular fraction cells | rel=r_associated | relid=0 | w=28
  106. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 28 / 0.667 -> en:anti-epidermal growth factor receptor 2 antibody expressing pluripotent killer t-lymphocytes
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:anti-epidermal growth factor receptor 2 antibody expressing pluripotent killer t-lymphocytes | rel=r_associated | relid=0 | w=28
  107. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 28 / 0.667 -> en:antigen
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:antigen | rel=r_associated | relid=0 | w=28
  108. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 28 / 0.667 -> en:autologous interferon-producing killer dendritic cells
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:autologous interferon-producing killer dendritic cells | rel=r_associated | relid=0 | w=28
  109. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 28 / 0.667 -> en:dr5-targeting tetrameric nanobody agonist tas266
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:dr5-targeting tetrameric nanobody agonist tas266 | rel=r_associated | relid=0 | w=28
  110. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 28 / 0.667 -> en:efs-ada lentiviral vector-transduced cd34-positive autologous lymphocytes
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:efs-ada lentiviral vector-transduced cd34-positive autologous lymphocytes | rel=r_associated | relid=0 | w=28
  111. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 28 / 0.667 -> en:filgrastim-primed peripheral blood progenitor cells
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:filgrastim-primed peripheral blood progenitor cells | rel=r_associated | relid=0 | w=28
  112. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 28 / 0.667 -> en:human placenta hydrolysate
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:human placenta hydrolysate | rel=r_associated | relid=0 | w=28
  113. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 28 / 0.667 -> en:immunotoxin
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:immunotoxin | rel=r_associated | relid=0 | w=28
  114. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 28 / 0.667 -> en:lentivirus vector ccr5 shrna/trim5alpha/tar decoy-transduced autologous cd34-positive hematopoietic progenitor cells
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:lentivirus vector ccr5 shrna/trim5alpha/tar decoy-transduced autologous cd34-positive hematopoietic progenitor cells | rel=r_associated | relid=0 | w=28
  115. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 28 / 0.667 -> en:microbial agent
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:microbial agent | rel=r_associated | relid=0 | w=28
  116. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 28 / 0.667 -> en:monoclonal antibody agent
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:monoclonal antibody agent | rel=r_associated | relid=0 | w=28
  117. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 28 / 0.667 -> en:oncolytic virus
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:oncolytic virus | rel=r_associated | relid=0 | w=28
  118. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 28 / 0.667 -> en:recombinant cytokine
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:recombinant cytokine | rel=r_associated | relid=0 | w=28
  119. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 28 / 0.667 -> en:topical wound spray hp802-247
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:topical wound spray hp802-247 | rel=r_associated | relid=0 | w=28
  120. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 27 / 0.643 -> en:algal product
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:algal product | rel=r_associated | relid=0 | w=27
  121. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 27 / 0.643 -> en:anti-programmed cell death protein 1 antibody expressing pluripotent killer t-lymphocytes
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:anti-programmed cell death protein 1 antibody expressing pluripotent killer t-lymphocytes | rel=r_associated | relid=0 | w=27
  122. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 27 / 0.643 -> en:cd28car/cd137car-expressing t-lymphocytes
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:cd28car/cd137car-expressing t-lymphocytes | rel=r_associated | relid=0 | w=27
  123. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 27 / 0.643 -> en:collagen
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:collagen | rel=r_associated | relid=0 | w=27
  124. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 27 / 0.643 -> en:collagen + procollagen
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:collagen + procollagen | rel=r_associated | relid=0 | w=27
  125. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 27 / 0.643 -> en:hemostasis related substance
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:hemostasis related substance | rel=r_associated | relid=0 | w=27
  126. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 27 / 0.643 -> en:ny-eso-1-specific tcr gene-transduced t lymphocytes tbi-1301
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:ny-eso-1-specific tcr gene-transduced t lymphocytes tbi-1301 | rel=r_associated | relid=0 | w=27
  127. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 27 / 0.643 -> en:oncolytic adenovirus icovir5-infected autologous mesenchymal stem cells
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:oncolytic adenovirus icovir5-infected autologous mesenchymal stem cells | rel=r_associated | relid=0 | w=27
  128. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 27 / 0.643 -> en:plant exudates
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:plant exudates | rel=r_associated | relid=0 | w=27
  129. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 27 / 0.643 -> en:protein
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:protein | rel=r_associated | relid=0 | w=27
  130. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 27 / 0.643 -> en:recombinant growth factor
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:recombinant growth factor | rel=r_associated | relid=0 | w=27
  131. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 24 / 0.571 -> protéine
    n1=en:4scar-gd2-modified t-lymphocytes | n2=protéine | rel=r_associated | relid=0 | w=24
  132. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 20 / 0.476 -> anticorps monoclonal
    n1=en:4scar-gd2-modified t-lymphocytes | n2=anticorps monoclonal | rel=r_associated | relid=0 | w=20
  133. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 20 / 0.476 -> Anticorps monoclonal
    n1=en:4scar-gd2-modified t-lymphocytes | n2=Anticorps monoclonal | rel=r_associated | relid=0 | w=20
  134. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 20 / 0.476 -> antigène
    n1=en:4scar-gd2-modified t-lymphocytes | n2=antigène | rel=r_associated | relid=0 | w=20
  135. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 20 / 0.476 -> cow-pox
    n1=en:4scar-gd2-modified t-lymphocytes | n2=cow-pox | rel=r_associated | relid=0 | w=20
  136. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 20 / 0.476 -> cowpox
    n1=en:4scar-gd2-modified t-lymphocytes | n2=cowpox | rel=r_associated | relid=0 | w=20
  137. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 20 / 0.476 -> en:allogeneic cd19car-transfected cytokine-induced killer cells
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:allogeneic cd19car-transfected cytokine-induced killer cells | rel=r_associated | relid=0 | w=20
  138. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 20 / 0.476 -> en:allogeneic ic9/cd19-car-cd28-zeta-2a-il15-transduced cord blood-derived natural killer cells tak-007
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:allogeneic ic9/cd19-car-cd28-zeta-2a-il15-transduced cord blood-derived natural killer cells tak-007 | rel=r_associated | relid=0 | w=20
  139. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 20 / 0.476 -> en:autologous egfrt/19-28z/4-1bbl car t-lymphocytes
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:autologous egfrt/19-28z/4-1bbl car t-lymphocytes | rel=r_associated | relid=0 | w=20
  140. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 20 / 0.476 -> en:autologous monocytes
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:autologous monocytes | rel=r_associated | relid=0 | w=20
  141. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 20 / 0.476 -> en:azercabtagene zapreleucel
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:azercabtagene zapreleucel | rel=r_associated | relid=0 | w=20
  142. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 20 / 0.476 -> en:cowpox
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:cowpox | rel=r_associated | relid=0 | w=20
  143. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 20 / 0.476 -> en:human menopausal gonadotrophin
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:human menopausal gonadotrophin | rel=r_associated | relid=0 | w=20
  144. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 20 / 0.476 -> en:meat and bone flour
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:meat and bone flour | rel=r_associated | relid=0 | w=20
  145. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 20 / 0.476 -> en:mirasol-treated allogeneic platelets
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:mirasol-treated allogeneic platelets | rel=r_associated | relid=0 | w=20
  146. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 20 / 0.476 -> en:monoclonal ab
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:monoclonal ab | rel=r_associated | relid=0 | w=20
  147. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 20 / 0.476 -> en:virus-specific cytotoxic t-lymphocytes
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:virus-specific cytotoxic t-lymphocytes | rel=r_associated | relid=0 | w=20
  148. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 20 / 0.476 -> farine animale
    n1=en:4scar-gd2-modified t-lymphocytes | n2=farine animale | rel=r_associated | relid=0 | w=20
  149. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 20 / 0.476 -> gène
    n1=en:4scar-gd2-modified t-lymphocytes | n2=gène | rel=r_associated | relid=0 | w=20
  150. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 20 / 0.476 -> gene
    n1=en:4scar-gd2-modified t-lymphocytes | n2=gene | rel=r_associated | relid=0 | w=20
  151. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 20 / 0.476 -> génique
    n1=en:4scar-gd2-modified t-lymphocytes | n2=génique | rel=r_associated | relid=0 | w=20
  152. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 20 / 0.476 -> gonadotrophine de femmes ménopausées
    n1=en:4scar-gd2-modified t-lymphocytes | n2=gonadotrophine de femmes ménopausées | rel=r_associated | relid=0 | w=20
  153. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 20 / 0.476 -> gonadotrophine ménopausique humaine
    n1=en:4scar-gd2-modified t-lymphocytes | n2=gonadotrophine ménopausique humaine | rel=r_associated | relid=0 | w=20
  154. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 20 / 0.476 -> hormone gonadotrope ménopausique humaine
    n1=en:4scar-gd2-modified t-lymphocytes | n2=hormone gonadotrope ménopausique humaine | rel=r_associated | relid=0 | w=20
  155. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 20 / 0.476 -> immunotoxine
    n1=en:4scar-gd2-modified t-lymphocytes | n2=immunotoxine | rel=r_associated | relid=0 | w=20
  156. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 20 / 0.476 -> interleukine 2
    n1=en:4scar-gd2-modified t-lymphocytes | n2=interleukine 2 | rel=r_associated | relid=0 | w=20
  157. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 20 / 0.476 -> monoclonal antibody
    n1=en:4scar-gd2-modified t-lymphocytes | n2=monoclonal antibody | rel=r_associated | relid=0 | w=20
  158. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 20 / 0.476 -> protein
    n1=en:4scar-gd2-modified t-lymphocytes | n2=protein | rel=r_associated | relid=0 | w=20
  159. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 20 / 0.476 -> proteine
    n1=en:4scar-gd2-modified t-lymphocytes | n2=proteine | rel=r_associated | relid=0 | w=20
  160. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 20 / 0.476 -> vaccin microbien
    n1=en:4scar-gd2-modified t-lymphocytes | n2=vaccin microbien | rel=r_associated | relid=0 | w=20
  161. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 20 / 0.476 -> vaccinal
    n1=en:4scar-gd2-modified t-lymphocytes | n2=vaccinal | rel=r_associated | relid=0 | w=20
  162. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 20 / 0.476 -> vaccine
    n1=en:4scar-gd2-modified t-lymphocytes | n2=vaccine | rel=r_associated | relid=0 | w=20
  163. en:4scar-gd2-modified t-lymphocytes -- r_associated #0: 20 / 0.476 -> variole de la vache
    n1=en:4scar-gd2-modified t-lymphocytes | n2=variole de la vache | rel=r_associated | relid=0 | w=20
≈ 209 relations entrantes

  1. protein --- r_associated #0: 825 --> en:4scar-gd2-modified t-lymphocytes
    n1=protein | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=825
  2. protéine --- r_associated #0: 798.95 --> en:4scar-gd2-modified t-lymphocytes
    n1=protéine | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=798.95
  3. en:protein --- r_associated #0: 798.67 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:protein | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=798.67
  4. proteine --- r_associated #0: 305 --> en:4scar-gd2-modified t-lymphocytes
    n1=proteine | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=305
  5. en:human menopausal gonadotropin --- r_associated #0: 136 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:human menopausal gonadotropin | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=136
  6. anticorps monoclonal --- r_associated #0: 135 --> en:4scar-gd2-modified t-lymphocytes
    n1=anticorps monoclonal | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=135
  7. gonadotrophine ménopausique humaine --- r_associated #0: 135 --> en:4scar-gd2-modified t-lymphocytes
    n1=gonadotrophine ménopausique humaine | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=135
  8. en:monoclonal antibody --- r_associated #0: 131 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:monoclonal antibody | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=131
  9. monoclonal antibody --- r_associated #0: 125 --> en:4scar-gd2-modified t-lymphocytes
    n1=monoclonal antibody | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=125
  10. cow-pox --- r_associated #0: 118 --> en:4scar-gd2-modified t-lymphocytes
    n1=cow-pox | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=118
  11. cowpox --- r_associated #0: 117 --> en:4scar-gd2-modified t-lymphocytes
    n1=cowpox | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=117
  12. en:cowpox --- r_associated #0: 115 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:cowpox | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=115
  13. vaccin microbien --- r_associated #0: 75 --> en:4scar-gd2-modified t-lymphocytes
    n1=vaccin microbien | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=75
  14. en:vaccine --- r_associated #0: 71 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:vaccine | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=71
  15. Anticorps monoclonal --- r_associated #0: 50 --> en:4scar-gd2-modified t-lymphocytes
    n1=Anticorps monoclonal | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=50
  16. en:gene --- r_associated #0: 45 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:gene | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=45
  17. hormone gonadotrope ménopausique humaine --- r_associated #0: 44 --> en:4scar-gd2-modified t-lymphocytes
    n1=hormone gonadotrope ménopausique humaine | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=44
  18. en:alpha-1-proteinase inhibitor human --- r_associated #0: 42 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:alpha-1-proteinase inhibitor human | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=42
  19. en:human placenta hydrolysate --- r_associated #0: 42 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:human placenta hydrolysate | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=42
  20. gene --- r_associated #0: 42 --> en:4scar-gd2-modified t-lymphocytes
    n1=gene | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=42
  21. antigène --- r_associated #0: 39 --> en:4scar-gd2-modified t-lymphocytes
    n1=antigène | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=39
  22. en:dehydrated human amnion/chorion membrane --- r_associated #0: 38 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:dehydrated human amnion/chorion membrane | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=38
  23. gène --- r_associated #0: 38 --> en:4scar-gd2-modified t-lymphocytes
    n1=gène | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=38
  24. en:antigen --- r_associated #0: 36 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:antigen | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=36
  25. immunotoxine --- r_associated #0: 36 --> en:4scar-gd2-modified t-lymphocytes
    n1=immunotoxine | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=36
  26. en:anti-epidermal growth factor receptor 2 antibody expressing pluripotent killer t-lymphocytes --- r_associated #0: 35 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:anti-epidermal growth factor receptor 2 antibody expressing pluripotent killer t-lymphocytes | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=35
  27. en:bcma-specific car-expressing t lymphocytes --- r_associated #0: 35 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:bcma-specific car-expressing t lymphocytes | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=35
  28. en:biosimilar pharmaceuticals --- r_associated #0: 35 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:biosimilar pharmaceuticals | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=35
  29. en:blood group antigen carrier --- r_associated #0: 35 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:blood group antigen carrier | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=35
  30. en:dendritic cell-precision multiple antigen t-lymphocytes --- r_associated #0: 35 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:dendritic cell-precision multiple antigen t-lymphocytes | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=35
  31. en:human immunoglobulin a --- r_associated #0: 35 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:human immunoglobulin a | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=35
  32. en:monoclonal antibody agent --- r_associated #0: 35 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:monoclonal antibody agent | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=35
  33. vaccine --- r_associated #0: 35 --> en:4scar-gd2-modified t-lymphocytes
    n1=vaccine | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=35
  34. en:recombinant cytokine --- r_associated #0: 34 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:recombinant cytokine | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=34
  35. en:human menopausal gonadotrophin --- r_associated #0: 33 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:human menopausal gonadotrophin | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=33
  36. interleukine 2 --- r_associated #0: 33 --> en:4scar-gd2-modified t-lymphocytes
    n1=interleukine 2 | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=33
  37. en:escherichia coli antibody --- r_associated #0: 32 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:escherichia coli antibody | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=32
  38. en:gene transfer or gene delivery agent --- r_associated #0: 32 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:gene transfer or gene delivery agent | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=32
  39. en:immunotoxin --- r_associated #0: 32 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:immunotoxin | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=32
  40. en:lentivirus vector rhiv7-shi-tar-ccr5rz-transduced hematopoietic progenitor cells --- r_associated #0: 32 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:lentivirus vector rhiv7-shi-tar-ccr5rz-transduced hematopoietic progenitor cells | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=32
  41. en:neurotransmitter --- r_associated #0: 32 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:neurotransmitter | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=32
  42. en:plant nectar --- r_associated #0: 32 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:plant nectar | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=32
  43. en:synthetic copolymer --- r_associated #0: 32 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:synthetic copolymer | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=32
  44. en:therapeutic autologous lymphocytes --- r_associated #0: 32 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:therapeutic autologous lymphocytes | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=32
  45. en:thrombopoietin receptor agonist lgd-4665 --- r_associated #0: 32 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:thrombopoietin receptor agonist lgd-4665 | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=32
  46. en:cathelicidin ll-37 --- r_associated #0: 31 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:cathelicidin ll-37 | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=31
  47. en:interleukin-2 --- r_associated #0: 31 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:interleukin-2 | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=31
  48. en:live yeast cell derivative --- r_associated #0: 31 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:live yeast cell derivative | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=31
  49. génique --- r_associated #0: 31 --> en:4scar-gd2-modified t-lymphocytes
    n1=génique | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=31
  50. en:algal product --- r_associated #0: 30 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:algal product | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=30
  51. en:autologous mesenchymal stem cells apceth_101 --- r_associated #0: 30 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:autologous mesenchymal stem cells apceth_101 | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=30
  52. en:bone meal --- r_associated #0: 30 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:bone meal | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=30
  53. en:cells [chemical/ingredient] --- r_associated #0: 30 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:cells [chemical/ingredient] | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=30
  54. en:chemotactic factor inactivator --- r_associated #0: 30 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:chemotactic factor inactivator | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=30
  55. en:dual variable domain immunoglobulin abt-165 --- r_associated #0: 30 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:dual variable domain immunoglobulin abt-165 | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=30
  56. en:efs-ada lentiviral vector-transduced cd34-positive autologous lymphocytes --- r_associated #0: 30 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:efs-ada lentiviral vector-transduced cd34-positive autologous lymphocytes | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=30
  57. en:lymphoma taa-specific cytotoxic t lymphocytes --- r_associated #0: 30 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:lymphoma taa-specific cytotoxic t lymphocytes | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=30
  58. en:meat and bone flour --- r_associated #0: 30 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:meat and bone flour | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=30
  59. en:mesothelin-specific chimeric antigen receptor-engineered peripheral blood lymphocytes --- r_associated #0: 30 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:mesothelin-specific chimeric antigen receptor-engineered peripheral blood lymphocytes | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=30
  60. en:microbial agent --- r_associated #0: 30 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:microbial agent | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=30
  61. en:mirasol-treated allogeneic platelets --- r_associated #0: 30 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:mirasol-treated allogeneic platelets | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=30
  62. en:monoclonal ab --- r_associated #0: 30 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:monoclonal ab | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=30
  63. en:ny-eso-1-specific tcr gene-transduced t lymphocytes tbi-1301 --- r_associated #0: 30 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:ny-eso-1-specific tcr gene-transduced t lymphocytes tbi-1301 | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=30
  64. en:recombinant human apolipoprotein(a) kringle v mg1102 --- r_associated #0: 30 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:recombinant human apolipoprotein(a) kringle v mg1102 | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=30
  65. en:serum-derived bovine immunoglobulin protein isolate --- r_associated #0: 30 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:serum-derived bovine immunoglobulin protein isolate | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=30
  66. en:virus-specific cytotoxic t-lymphocytes --- r_associated #0: 30 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:virus-specific cytotoxic t-lymphocytes | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=30
  67. farine animale --- r_associated #0: 30 --> en:4scar-gd2-modified t-lymphocytes
    n1=farine animale | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=30
  68. gonadotrophine de femmes ménopausées --- r_associated #0: 30 --> en:4scar-gd2-modified t-lymphocytes
    n1=gonadotrophine de femmes ménopausées | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=30
  69. vaccinal --- r_associated #0: 30 --> en:4scar-gd2-modified t-lymphocytes
    n1=vaccinal | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=30
  70. en:autologous chondrocyte cell preparation --- r_associated #0: 29 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:autologous chondrocyte cell preparation | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=29
  71. en:azercabtagene zapreleucel --- r_associated #0: 29 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:azercabtagene zapreleucel | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=29
  72. en:calfactant --- r_associated #0: 29 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:calfactant | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=29
  73. en:colony stimulating factor --- r_associated #0: 29 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:colony stimulating factor | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=29
  74. en:gene therapy agent --- r_associated #0: 29 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:gene therapy agent | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=29
  75. en:human immunoglobulin g --- r_associated #0: 29 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:human immunoglobulin g | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=29
  76. en:oncolytic virus --- r_associated #0: 29 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:oncolytic virus | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=29
  77. en:recombinant growth factor --- r_associated #0: 29 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:recombinant growth factor | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=29
  78. en:ularitide --- r_associated #0: 29 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:ularitide | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=29
  79. en:umbilical cord blood-derived hematopoietic cd34-positive progenitor cells --- r_associated #0: 29 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:umbilical cord blood-derived hematopoietic cd34-positive progenitor cells | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=29
  80. variole de la vache --- r_associated #0: 29 --> en:4scar-gd2-modified t-lymphocytes
    n1=variole de la vache | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=29
  81. en:allogeneic ic9/cd19-car-cd28-zeta-2a-il15-transduced cord blood-derived natural killer cells tak-007 --- r_associated #0: 28 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:allogeneic ic9/cd19-car-cd28-zeta-2a-il15-transduced cord blood-derived natural killer cells tak-007 | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=28
  82. en:anti-programmed cell death protein 1 antibody expressing pluripotent killer t-lymphocytes --- r_associated #0: 28 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:anti-programmed cell death protein 1 antibody expressing pluripotent killer t-lymphocytes | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=28
  83. en:anti-prolactin receptor antibody lfa102 --- r_associated #0: 28 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:anti-prolactin receptor antibody lfa102 | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=28
  84. en:autologous monocytes --- r_associated #0: 28 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:autologous monocytes | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=28
  85. en:biological control agents --- r_associated #0: 28 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:biological control agents | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=28
  86. en:biological warfare agents --- r_associated #0: 28 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:biological warfare agents | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=28
  87. en:blood group antigen precursor --- r_associated #0: 28 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:blood group antigen precursor | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=28
  88. en:bovine pituitary extract --- r_associated #0: 28 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:bovine pituitary extract | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=28
  89. en:collagen --- r_associated #0: 28 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:collagen | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=28
  90. en:cord blood-derived expanded natural killer cells pnk-007 --- r_associated #0: 28 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:cord blood-derived expanded natural killer cells pnk-007 | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=28
  91. en:denileukin diftitox --- r_associated #0: 28 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:denileukin diftitox | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=28
  92. en:filgrastim-primed peripheral blood progenitor cells --- r_associated #0: 28 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:filgrastim-primed peripheral blood progenitor cells | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=28
  93. en:interleukin-11 --- r_associated #0: 28 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:interleukin-11 | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=28
  94. en:recombinant human serum amyloid p/pentraxin 2 --- r_associated #0: 28 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:recombinant human serum amyloid p/pentraxin 2 | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=28
  95. en:tumor-cells apoptosis factor hormone-peptide --- r_associated #0: 28 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:tumor-cells apoptosis factor hormone-peptide | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=28
  96. en:adipose-derived stromal vascular fraction cells --- r_associated #0: 27 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:adipose-derived stromal vascular fraction cells | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=27
  97. en:c46/ccr5/p140k lentiviral vector-transduced autologous hspcs --- r_associated #0: 27 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:c46/ccr5/p140k lentiviral vector-transduced autologous hspcs | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=27
  98. en:dr5-targeting tetrameric nanobody agonist tas266 --- r_associated #0: 27 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:dr5-targeting tetrameric nanobody agonist tas266 | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=27
  99. en:enzyme replacement or supplement agent --- r_associated #0: 27 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:enzyme replacement or supplement agent | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=27
  100. en:genetically engineered hematopoietic stem progenitor cells --- r_associated #0: 27 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:genetically engineered hematopoietic stem progenitor cells | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=27
  101. en:interferon beta-secreting mesenchymal stem cells --- r_associated #0: 27 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:interferon beta-secreting mesenchymal stem cells | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=27
  102. en:nutrient --- r_associated #0: 27 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:nutrient | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=27
  103. en:ny-eso-1-specific cd4-positive t lymphocytes --- r_associated #0: 27 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:ny-eso-1-specific cd4-positive t lymphocytes | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=27
  104. en:oncolytic adenovirus icovir5-infected autologous mesenchymal stem cells --- r_associated #0: 27 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:oncolytic adenovirus icovir5-infected autologous mesenchymal stem cells | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=27
  105. en:ovine digoxin immune fab --- r_associated #0: 27 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:ovine digoxin immune fab | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=27
  106. en:plant preparations --- r_associated #0: 27 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:plant preparations | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=27
  107. en:viruses ingredient --- r_associated #0: 27 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:viruses ingredient | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=27
  108. en:acellular cadaveric dermal matrix --- r_associated #0: 26 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:acellular cadaveric dermal matrix | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=26
  109. en:allogeneic cd19car-transfected cytokine-induced killer cells --- r_associated #0: 26 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:allogeneic cd19car-transfected cytokine-induced killer cells | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=26
  110. en:anti-cd22 car-expressing t lymphocytes --- r_associated #0: 26 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:anti-cd22 car-expressing t lymphocytes | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=26
  111. en:anti-tumor necrosis factor alpha drug --- r_associated #0: 26 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:anti-tumor necrosis factor alpha drug | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=26
  112. en:antisense oligonucleotides --- r_associated #0: 26 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:antisense oligonucleotides | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=26
  113. en:antiserum --- r_associated #0: 26 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:antiserum | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=26
  114. en:autologous egfrt/19-28z/4-1bbl car t-lymphocytes --- r_associated #0: 26 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:autologous egfrt/19-28z/4-1bbl car t-lymphocytes | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=26
  115. en:autologous interferon-producing killer dendritic cells --- r_associated #0: 26 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:autologous interferon-producing killer dendritic cells | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=26
  116. en:fap-specific cd8-positive t cells --- r_associated #0: 26 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:fap-specific cd8-positive t cells | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=26
  117. en:hemostasis related substance --- r_associated #0: 26 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:hemostasis related substance | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=26
  118. en:luspatercept --- r_associated #0: 26 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:luspatercept | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=26
  119. en:red yeast rice --- r_associated #0: 26 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:red yeast rice | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=26
  120. en:therapeutic allogeneic lymphocytes --- r_associated #0: 26 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:therapeutic allogeneic lymphocytes | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=26
  121. en:therapeutic angiotensin-(1-7) --- r_associated #0: 26 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:therapeutic angiotensin-(1-7) | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=26
  122. en:topical wound spray hp802-247 --- r_associated #0: 26 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:topical wound spray hp802-247 | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=26
  123. en:transduction gene --- r_associated #0: 26 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:transduction gene | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=26
  124. en:vaccine, immunoglobulin, and/or antiserum --- r_associated #0: 26 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:vaccine, immunoglobulin, and/or antiserum | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=26
  125. en:gelatin --- r_associated #0: 25 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:gelatin | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=25
  126. en:genetically engineered ny-eso-1-specific t lymphocytes --- r_associated #0: 25 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:genetically engineered ny-eso-1-specific t lymphocytes | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=25
  127. en:hsp70-peptide tkd/il-2-activated autologous natural killer cells --- r_associated #0: 25 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:hsp70-peptide tkd/il-2-activated autologous natural killer cells | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=25
  128. en:organic natural material --- r_associated #0: 25 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:organic natural material | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=25
  129. en:picibanil --- r_associated #0: 25 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:picibanil | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=25
  130. en:toxoids --- r_associated #0: 25 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:toxoids | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=25
  131. en:blood derivative product --- r_associated #0: 24 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:blood derivative product | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=24
  132. en:cd28car/cd137car-expressing t-lymphocytes --- r_associated #0: 24 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:cd28car/cd137car-expressing t-lymphocytes | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=24
  133. en:gene transduction agent --- r_associated #0: 24 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:gene transduction agent | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=24
  134. en:hematopoietic factor --- r_associated #0: 24 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:hematopoietic factor | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=24
  135. en:lenti-d/abcd1-transduced autologous hematopoietic stem cells --- r_associated #0: 24 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:lenti-d/abcd1-transduced autologous hematopoietic stem cells | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=24
  136. en:lentivirus vector ccr5 shrna/trim5alpha/tar decoy-transduced autologous cd34-positive hematopoietic progenitor cells --- r_associated #0: 24 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:lentivirus vector ccr5 shrna/trim5alpha/tar decoy-transduced autologous cd34-positive hematopoietic progenitor cells | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=24
  137. en:protein-bound iodine --- r_associated #0: 24 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:protein-bound iodine | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=24
  138. en:superagonist interleukin-15:interleukin-15 receptor alphasu/fc fusion complex alt-803 --- r_associated #0: 24 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:superagonist interleukin-15:interleukin-15 receptor alphasu/fc fusion complex alt-803 | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=24
  139. en:blood material --- r_associated #0: 23 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:blood material | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=23
  140. en:botulinum toxins --- r_associated #0: 23 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:botulinum toxins | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=23
  141. en:gene-modified hiv-protected hematopoietic stem cells --- r_associated #0: 23 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:gene-modified hiv-protected hematopoietic stem cells | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=23
  142. en:heterodimeric interleukin-15 --- r_associated #0: 23 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:heterodimeric interleukin-15 | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=23
  143. en:inducible cd4+cd25+ regulatory t cells --- r_associated #0: 23 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:inducible cd4+cd25+ regulatory t cells | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=23
  144. en:nervous system hormone-like substance --- r_associated #0: 23 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:nervous system hormone-like substance | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=23
  145. en:plant exudates --- r_associated #0: 23 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:plant exudates | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=23
  146. en:vaccine, immunoglobulins and antisera --- r_associated #0: 23 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:vaccine, immunoglobulins and antisera | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=23
  147. protide --- r_associated #0: 23 --> en:4scar-gd2-modified t-lymphocytes
    n1=protide | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=23
  148. en:autologous anti-hpv-16 e6 t-cell receptor gene-engineered peripheral blood lymphocytes --- r_associated #0: 22 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:autologous anti-hpv-16 e6 t-cell receptor gene-engineered peripheral blood lymphocytes | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=22
  149. en:autologous pbmcs in gm-csf --- r_associated #0: 22 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:autologous pbmcs in gm-csf | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=22
  150. en:donor regulatory t-lymphocytes --- r_associated #0: 22 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:donor regulatory t-lymphocytes | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=22
  151. en:expanded umbilical cord blood product hsc835 --- r_associated #0: 22 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:expanded umbilical cord blood product hsc835 | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=22
  152. en:growth substances --- r_associated #0: 22 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:growth substances | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=22
  153. en:human immunoglobulin m --- r_associated #0: 22 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:human immunoglobulin m | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=22
  154. en:igf-1r antisense oligodeoxynucleotide-treated autologous glioma cells --- r_associated #0: 22 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:igf-1r antisense oligodeoxynucleotide-treated autologous glioma cells | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=22
  155. en:immunologic factors --- r_associated #0: 22 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:immunologic factors | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=22
  156. en:receptor --- r_associated #0: 22 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:receptor | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=22
  157. en:saccharomyces cerevisiae rna --- r_associated #0: 22 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:saccharomyces cerevisiae rna | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=22
  158. en:sirna-transfected peripheral blood mononuclear cells apn401 --- r_associated #0: 22 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:sirna-transfected peripheral blood mononuclear cells apn401 | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=22
  159. en:autologous cd34-positive hematopoietic progenitor cells --- r_associated #0: 21 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:autologous cd34-positive hematopoietic progenitor cells | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=21
  160. en:beractant --- r_associated #0: 21 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:beractant | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=21
  161. en:blood product --- r_associated #0: 21 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:blood product | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=21
  162. en:cd138car-cd137/tcrzeta-expressing t lymphocytes --- r_associated #0: 21 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:cd138car-cd137/tcrzeta-expressing t lymphocytes | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=21
  163. en:collagen + procollagen --- r_associated #0: 21 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:collagen + procollagen | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=21
  164. en:her2-targeting antibody fc fragment fs102 --- r_associated #0: 21 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:her2-targeting antibody fc fragment fs102 | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=21
  165. neurotransmetteur --- r_associated #0: 21 --> en:4scar-gd2-modified t-lymphocytes
    n1=neurotransmetteur | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=21
  166. Cowper (glande de) --- r_associated #0: 15 --> en:4scar-gd2-modified t-lymphocytes
    n1=Cowper (glande de) | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=15
  167. Farine animale --- r_associated #0: 15 --> en:4scar-gd2-modified t-lymphocytes
    n1=Farine animale | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=15
  168. PROTEIN --- r_associated #0: 15 --> en:4scar-gd2-modified t-lymphocytes
    n1=PROTEIN | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=15
  169. Protéine --- r_associated #0: 15 --> en:4scar-gd2-modified t-lymphocytes
    n1=Protéine | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=15
  170. antigen --- r_associated #0: 15 --> en:4scar-gd2-modified t-lymphocytes
    n1=antigen | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=15
  171. produit dérivé du sang --- r_associated #0: 15 --> en:4scar-gd2-modified t-lymphocytes
    n1=produit dérivé du sang | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=15
  172. Ag
    (antigène)
     --- r_associated #0: 10 --> en:4scar-gd2-modified t-lymphocytes
    n1=Ag
    (antigène)
    | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=10
  173. Génique --- r_associated #0: 10 --> en:4scar-gd2-modified t-lymphocytes
    n1=Génique | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=10
  174. IL-2 --- r_associated #0: 10 --> en:4scar-gd2-modified t-lymphocytes
    n1=IL-2 | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=10
  175. Neurotransmetteur --- r_associated #0: 10 --> en:4scar-gd2-modified t-lymphocytes
    n1=Neurotransmetteur | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=10
  176. Protein --- r_associated #0: 10 --> en:4scar-gd2-modified t-lymphocytes
    n1=Protein | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=10
  177. Protée (syndrome de) --- r_associated #0: 10 --> en:4scar-gd2-modified t-lymphocytes
    n1=Protée (syndrome de) | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=10
  178. en:Cowper 's gland --- r_associated #0: 10 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:Cowper 's gland | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=10
  179. en:cow-pox --- r_associated #0: 10 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:cow-pox | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=10
  180. en:proteid --- r_associated #0: 10 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:proteid | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=10
  181. en:protide --- r_associated #0: 10 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:protide | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=10
  182. en:vaccinal --- r_associated #0: 10 --> en:4scar-gd2-modified t-lymphocytes
    n1=en:vaccinal | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=10
  183. géniculé (ganglion) --- r_associated #0: 10 --> en:4scar-gd2-modified t-lymphocytes
    n1=géniculé (ganglion) | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=10
  184. iode lié aux protéines --- r_associated #0: 10 --> en:4scar-gd2-modified t-lymphocytes
    n1=iode lié aux protéines | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=10
  185. nutriment --- r_associated #0: 10 --> en:4scar-gd2-modified t-lymphocytes
    n1=nutriment | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=10
  186. protidique --- r_associated #0: 10 --> en:4scar-gd2-modified t-lymphocytes
    n1=protidique | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=10
  187. substance du système nerveux à effet hormonal --- r_associated #0: 10 --> en:4scar-gd2-modified t-lymphocytes
    n1=substance du système nerveux à effet hormonal | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=10
  188. cowperite --- r_associated #0: 5 --> en:4scar-gd2-modified t-lymphocytes
    n1=cowperite | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=5
  189. cowpox virus --- r_associated #0: 5 --> en:4scar-gd2-modified t-lymphocytes
    n1=cowpox virus | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=5
  190. en protéines --- r_associated #0: 5 --> en:4scar-gd2-modified t-lymphocytes
    n1=en protéines | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=5
  191. facteur d'apoptose des cellules tumorales hormone-peptide --- r_associated #0: 5 --> en:4scar-gd2-modified t-lymphocytes
    n1=facteur d'apoptose des cellules tumorales hormone-peptide | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=5
  192. interféron (traitement par l') --- r_associated #0: 5 --> en:4scar-gd2-modified t-lymphocytes
    n1=interféron (traitement par l') | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=5
  193. interleukine 11 --- r_associated #0: 5 --> en:4scar-gd2-modified t-lymphocytes
    n1=interleukine 11 | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=5
  194. lymphocytes T CD4-positifs spécifiques de NY-ESO-1 --- r_associated #0: 5 --> en:4scar-gd2-modified t-lymphocytes
    n1=lymphocytes T CD4-positifs spécifiques de NY-ESO-1 | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=5
  195. lymphocytes T TBI-1301 transduits avec le gène TCR spécifique de NY-ESO-1 --- r_associated #0: 5 --> en:4scar-gd2-modified t-lymphocytes
    n1=lymphocytes T TBI-1301 transduits avec le gène TCR spécifique de NY-ESO-1 | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=5
  196. lymphocytes T cytotoxiques spécifiques du virus --- r_associated #0: 5 --> en:4scar-gd2-modified t-lymphocytes
    n1=lymphocytes T cytotoxiques spécifiques du virus | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=5
  197. lymphocytes T exprimant le CAR anti-CD22 --- r_associated #0: 5 --> en:4scar-gd2-modified t-lymphocytes
    n1=lymphocytes T exprimant le CAR anti-CD22 | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=5
  198. lymphocytes T exprimant un CAR spécifique au BCMA --- r_associated #0: 5 --> en:4scar-gd2-modified t-lymphocytes
    n1=lymphocytes T exprimant un CAR spécifique au BCMA | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=5
  199. lymphocytes T génétiquement modifiés spécifiques de NY-ESO-1 --- r_associated #0: 5 --> en:4scar-gd2-modified t-lymphocytes
    n1=lymphocytes T génétiquement modifiés spécifiques de NY-ESO-1 | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=5
  200. lymphocytes T régulateurs du donneur --- r_associated #0: 5 --> en:4scar-gd2-modified t-lymphocytes
    n1=lymphocytes T régulateurs du donneur | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=5
  201. lymphocytes T tueurs pluripotents exprimant l'anticorps anti-protéine 1 de mort cellulaire programmée --- r_associated #0: 5 --> en:4scar-gd2-modified t-lymphocytes
    n1=lymphocytes T tueurs pluripotents exprimant l'anticorps anti-protéine 1 de mort cellulaire programmée | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=5
  202. lymphocytes T tueurs pluripotents exprimant l'anticorps anti-récepteur 2 du facteur de croissance épidermique --- r_associated #0: 5 --> en:4scar-gd2-modified t-lymphocytes
    n1=lymphocytes T tueurs pluripotents exprimant l'anticorps anti-récepteur 2 du facteur de croissance épidermique | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=5
  203. lymphocytes T à antigènes multiples de précision des cellules dendritiques --- r_associated #0: 5 --> en:4scar-gd2-modified t-lymphocytes
    n1=lymphocytes T à antigènes multiples de précision des cellules dendritiques | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=5
  204. lymphocytes allogéniques thérapeutiques --- r_associated #0: 5 --> en:4scar-gd2-modified t-lymphocytes
    n1=lymphocytes allogéniques thérapeutiques | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=5
  205. lymphocytes autologues CD34-positifs transduits par vecteur lentiviral EFS-ADA --- r_associated #0: 5 --> en:4scar-gd2-modified t-lymphocytes
    n1=lymphocytes autologues CD34-positifs transduits par vecteur lentiviral EFS-ADA | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=5
  206. lymphocytes autologues thérapeutiques --- r_associated #0: 5 --> en:4scar-gd2-modified t-lymphocytes
    n1=lymphocytes autologues thérapeutiques | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=5
  207. lymphocytes du sang périphérique autologues génétiquement modifiés avec le récepteur des cellules T anti-HPV-16 E6 --- r_associated #0: 5 --> en:4scar-gd2-modified t-lymphocytes
    n1=lymphocytes du sang périphérique autologues génétiquement modifiés avec le récepteur des cellules T anti-HPV-16 E6 | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=5
  208. lymphocytes du sang périphérique modifiés avec un récepteur d'antigène chimérique spécifique à la mésothéline --- r_associated #0: 5 --> en:4scar-gd2-modified t-lymphocytes
    n1=lymphocytes du sang périphérique modifiés avec un récepteur d'antigène chimérique spécifique à la mésothéline | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=5
  209. lymphocytes t cytotoxiques spécifiques des taa du lymphome --- r_associated #0: 5 --> en:4scar-gd2-modified t-lymphocytes
    n1=lymphocytes t cytotoxiques spécifiques des taa du lymphome | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=5
Le service Rézo permet d'énumérer les relations existant pour un terme. Ce service est interrogeable par programme.
Projet JeuxDeMots - url: http://www.jeuxdemots.org
contact: mathieu.lafourcade@lirmm.fr